Farmers Edge Sees Exercise Of Over-Allotment Option, Bringing IPO Proceeds To $143.8 Million

Farmers Edge (TSX: FDGE) has seen further capital inflows in connection with its initial public offering. The firm this morning announced that it has now received an additional $18.8 million in funds as a result of the full exercise of its over-allotment option that was issued in connection with the financing.

A total of 1.1 million common shares were issued under the over-allotment option, bringing in $18,750,150 in additional funds, with common shares of the issuer sold at a price of $17.00 each. The additional sale brings total gross proceeds from the initial public offering, or IPO, to $143.8 million.

Farmers Edge last traded at $16.47 on the TSX.


Information for this briefing was found via Farmers Edge and Sedar. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Could Silver Stay This High? | Joaquín Marias – Argenta Silver

Can Historic Silver Data Turn Into a New Mine? | Rob Macdonald – Equity Metals

Is This the Most Overlooked Critical Mineral? (+1000% Move) | Guy Bourassa – Scandium Canada

Recommended

Mercado Minerals Launches Inaugural Drill Program at Copalito Project

Silver47 Launches 7,000-Meter Hughes Drill Program In Nevada

Related News

Singapore-Based A SPAC I Acquisition Prices US$60 Million IPO

Special purpose acquisition company A SPAC I Acquisition Corp. started trading on the Nasdaq Capital...

Tuesday, February 15, 2022, 02:19:00 PM

Start-Up EV Maker Rivian Files Paperwork for IPO

On August 27, the private start-up electric vehicle manufacturer Rivian submitted a widely anticipated confidential...

Tuesday, August 31, 2021, 03:37:00 PM

Jeb Bush-Chaired Healthcare SPAC Jackson Acquisition Prices US$200 Million IPO

Special purpose acquisition company Jackson Acquisition Company (NYSE: RJAC.U) went public today on the New...

Thursday, December 9, 2021, 02:17:00 PM

Oncology Firm Erasca Eyes US$300 Million IPO

Precision oncology company Erasca Inc. (NASDAQ: ERAS) began trading on the Nasdaq Global Select Market...

Friday, July 16, 2021, 11:20:00 AM

Biotech Firm OKYO Pharma Closes US$2.5 Million IPO

Biotech firm OKYO Pharma Limited (Nasdaq: OKYO) closed on Thursday its initial public offering on...

Saturday, May 21, 2022, 05:12:00 PM